Dasatinib Accord 140 mg, Filmtabletten - 30 Swissmedic Key 69965006 Registration Holder Accord Healthcare AG Name Dasatinib Accord 140 mg, Filmtabletten Date of registration 20.01.2025 Introduction of Sequence 20.01.2025 ATC-Classification Dasatinib (L01EA02) Revision date WHO WHO-DDD Valid until 19.01.2030 Index Therapeuticus (BSV) Show package size 30 Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680699650064 Medication Code Synthetika Pharmacode Disponibility
Composition dasatinibum 140 mg ut dasatinibum monohydricum, lactosum monohydricum 183.83 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium max. 2.02 mg, magnesii stearas, Überzug: hypromellosum, E 171, triacetinum, pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Dasatinib 140 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. Hydroxypropylcellulosum Hypromellosum Überzug Lactose Monohydrate 183.83 mg Magnesii Stearas Pro Compresso Obducto Triacetinum
Source Data was imported : 07.02.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
